ASLAN Pharmaceuticals Limited
ASLN
|
|
| |
|
| Trading Volume | 610,341 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 229.2M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | 58.3% | -19.6% |
| Q2 | - | - | - | -45% |
| Q3 | - | - | - | 21% |
| Q4 | - | - | - | -39.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 91.1 | 9.7 | -24.5 | - | - | - | - | - | - | - | - | - |
| 2022 | |||||||||||
| -15.2 | -9.5 | 4.7 | -24.9 | -40.2 | 22.5 | -7.3 | 35.1 | -3.4 | -32.6 | 36.1 | -34.6 |
| 2021 | |||||||||||
| 20 | 102.7 | -25.6 | -2.1 | -9.5 | 11.1 | -14.2 | -5.7 | -33.3 | -5.6 | -14.3 | -22.2 |
| 2020 | |||||||||||
| 1 | -7.7 | -45.3 | 65 | 4.6 | 13.6 | -24.5 | - | 23.2 | -11.8 | 4.3 | 8.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1.3 | -1 | -0.1 | -0.1 |
| Q2 | -0.1 | -1.8 | 0 | -0.1 |
| Q3 | -0.6 | -0.8 | -0.1 | -0.1 |
| Q4 | 0 | -0.2 | -0.2 | -0.1 |
| A | -1.96 | -3.68 | -0.4 | -0.4 |